Lexeo Therapeutics Inc. C...

NASDAQ: LXEO · Real-Time Price · USD
4.71
-0.08 (-1.67%)
At close: Aug 15, 2025, 3:59 PM
4.72
0.21%
After-hours: Aug 15, 2025, 05:36 PM EDT

Lexeo Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-98.33M -66.39M -59.28M -50.62M
Depreciation & Amortization
2M 1.84M 1.15M 13.4K
Stock-Based Compensation
12.47M 3.04M 1.78M 386K
Other Working Capital
351K 1.66M 2.22M 3.03M
Other Non-Cash Items
n/a 530K n/a -692
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
2.73M 1.48M 1.79M 6.04M
Operating Cash Flow
-81.15M -59.5M -54.56M -44.18M
Capital Expenditures
-481K -165K -901K -188K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-93.6M n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a -50K -229K n/a
Investing Cash Flow
-94.08M -165K -901K -188K
Debt Repayment
-410K 3.58M -163K n/a
Common Stock Repurchased
-17K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
491K -35K 332K -203K
Financial Cash Flow
88.78M 103.79M 189K 150.86M
Net Cash Flow
-86.45M 44.13M -55.27M 106.49M
Free Cash Flow
-81.63M -59.66M -55.46M -44.37M